news_6

Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

Sparsentan is a potential first-in-class treatment to address significant unmet medical need in rare kidney disorders focal segmental glomerulosclerosis (FSGS)...

generic_link-67

StaffAny Announces the Launch of Sales-based Scheduling, a New Product Feature for Managers and HR to Schedule Based on Sales and Labour Productivity Goals

SINGAPORE - Media OutReach - 16 September 2021 - StaffAny, a staff scheduling, clock-in and timesheets tool, has just launched their latest...

news_6

10×1000 Launches “Flex” Fintech Program with Partners Worldwide to Bridge Global Digital Skills Gap and Drive Financial Inclusion

SHANGHAI--(BUSINESS WIRE)--Fintech training platform 10x1000 Tech for Inclusion announced that it will deepen its collaborations with partners worldwide, working with...

news_6

Announcing the Use of Gunze’s Meniscal Repair Biodegradable Scaffolds for a Clinical Trial to Improve the Outcome of Medial Meniscal Injury Patients at Osaka Medical and Pharmaceutical University

OSAKA, Japan--(BUSINESS WIRE)--#QOL--Gunze Limited (Headquarters: Osaka, Japan, President: Toshiyasu Saguchi) is pleased to announce the use of Gunze’s biodegradable scaffolds...